THE LUPUS LOW DISEASE ACTIVITY STATE (LLDAS) DEFINITION DISCRIMINATES RESPONDERS IN A SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) TRIAL: POST-HOC ANALYSIS OF THE PHASE IIB MUSE TRIAL OF ANIFROLUMAB

被引：1

作者：

Morand, E. ^{[1
]}

Berglind, A. ^{[2
]}

Sheytanova, T. ^{[2
]}

Tummala, R. ^{[2
]}

Illei, G. ^{[3
]}

机构：

[1] Monash Univ, Melbourne, Vic, Australia

[2] AstraZeneca, Molndal, Sweden

[3] MedImmune LLC, Gaithersburg, MD USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷

关键词：

D O I：

10.1136/annrheumdis-2017-eular.2464

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OP0001

引用

页码：50 / 50

页数：1

共 50 条

[41] Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus [J].

Matteo Piga ;

Alberto Floris ;

Giulia Cappellazzo ;

Elisabetta Chessa ;

Mattia Congia ;

Alessandro Mathieu ;

Alberto Cauli .

Arthritis Research & Therapy, 19

[42] EFFECTS OF ATACICEPT ON DISEASE ACTIVITY IN PATIENTS WITH MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS: APRIL-SLE RANDOMIZED TRIAL [J].

Gordon, C. ;

Isenberg, D. ;

Li, Y. ;

Wax, S. ;

Wofsy, D. ;

Rossi, C. Pena .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 :77-77

[43] LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort [J].

Ugarte-Gil, Manuel Francisco ;

Gamboa-Cardenas, Rocio Violeta ;

Reategui-Sokolova, Cristina ;

Pimentel-Quiroz, Victor Roman ;

Medina, Mariela ;

Elera-Fitzcarrald, Claudia ;

Zevallos, Francisco ;

Pastor-Asurza, Cesar Augusto ;

Lofland, Jeniffer ;

Zazzetti, Federico ;

Karyekar, Chetan S. ;

Alarcon, Graciela S. ;

Perich-Campos, Risto Alfredo .

LUPUS SCIENCE & MEDICINE, 2022, 9 (01)

[44] Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme [J].

Maslen, Toni ;

Bruce, Ian N. ;

D'Cruz, David ;

Ianosev, Mihaela ;

Bass, Damon L. ;

Wilkinson, Christel ;

Roth, David A. .

LUPUS SCIENCE & MEDICINE, 2021, 8 (01)

[45] Disease activity and glucocorticoid tapering patterns in Japanese patients with systemic lupus erythematosus treated with anifrolumab: Post hoc analysis of the Japanese subpopulation of the TULIP-2 study [J].

Tanaka, Yoshiya ;

Atsumi, Tatsuya ;

Okada, Masato ;

Miyamura, Tomoya ;

Ishii, Tomonori ;

Nishiyama, Susumu ;

Matsumura, Ryutaro ;

Morishima, Yosuke ;

Yamaguchi, Yoshiyuki ;

Abreu, Gabriel ;

Lindholm, Catharina ;

Morand, Eric F. ;

Takeuchi, Tsutomu .

MODERN RHEUMATOLOGY, 2025, 35 (03) :470-477

[46] Lupus Disease Activity After Cessation of Anifrolumab Treatment During the Phase 2b MUSE Trial Follow-up Period [J].

Furie, Richard ;

Kalunian, Kenneth ;

Merrill, Joan ;

Abreu, Gabriel ;

Tummala, Raj .

ARTHRITIS & RHEUMATOLOGY, 2020, 72

[47] LUPUS LOW DISEASE ACTIVITY STATE ATTAINMENT IN THE PHASE 3 PLACEBO-CONTROLLED TULIP LONG-TERM EXTENSION TRIAL OF ANIFROLUMAB [J].

Morand, E. F. ;

Van Vollenhoven, R. ;

Furie, R. ;

Kalunian, K. ;

Yavuz, S. ;

Abreu, G. ;

Lindholm, C. ;

Al-Mossawi, H. .

ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :33-34

[48] Efficacy Of Rituximab In Patients With Refractory Lupus Nephritis, a Post-Hoc Analysis From Phase II Trial In Japan. [J].

Tanaka, Yoshiya ;

Yamamoto, Kazuhiko ;

Takeuchi, Tsutomu ;

Miyasaka, Nobuyuki ;

Sumida, Takayuki ;

Mimori, Tsuneyo ;

Koike, Takao ;

Endo, Kazuhiro .

ARTHRITIS AND RHEUMATISM, 2013, 65 :S253-S254

[49] Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials [J].

Parodis, Ioannis ;

Lindblom, Julius ;

Levy, Roger A. ;

Zen, Margherita ;

Cetrez, Nursen ;

Gomez, Alvaro ;

Oon, Shereen ;

Henning, Christine ;

Khamashta, Munther ;

Quasny, Holly A. ;

Chauhan, Deven ;

Askanase, Anca ;

van Vollenhoven, Ronald ;

Nikpour, Mandana .

LANCET RHEUMATOLOGY, 2024, 6 (11) :e751-e761

[50] Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the Phase 2 clinical trial with blisibimod [J].

Petri, M. A. ;

Martin, R. S. ;

Scheinberg, M. A. ;

Furie, R. A. .

LUPUS, 2017, 26 (01) :27-37

← 1 2 3 4 5 →